Latest Round of FTC CBD Letter-Writing Campaign Has Anonymous
Pen Pals
Three companies get talking-to over CBD health
claims
Ambitious!
Three unnamed companies were on the receiving end of firm but
undoubtedly polite letters from the Federal Trade Commission
warning them to take a long, hard look at their cannabidiol (CBD)
advertising.
Using scare quotes designed to make them seem like dangerously
unhip parents, the commission announced that the missives were sent
to "three companies that sell oils, tinctures, capsules,
'gummies,' and creams containing cannabidiol (CBD), a
chemical compound derived from the cannabis plant."
Apparently the anonymous companies have been claiming that their
CBD-related products cure or alleviate a variety of conditions,
including (take a deep breath) cancer, Alzheimer's disease,
arthritis, multiple sclerosis, cigarette addiction, colitis,
autism, anorexia, bipolar disorder, post-traumatic stress disorder,
schizophrenia,